The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schulz Marcus since 2020.
This trader's CIK number is 1812702.
At the time of last reporting, Schulz Marcus was the Chief Revenue Officer of Biolife Solutions Inc. (stock ticker symbol BLFS).
Also see all insider trading activities at Biolife Solutions Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | BLFS | 0 | $0 | 9,048 | $203,492 | 0 | $0 |
| 2022 | BLFS | 0 | $0 | 7,572 | $156,104 | 0 | $0 |
| 2021 | BLFS | 0 | $0 | 13,035 | $585,717 | 0 | $0 |
| 2020 | BLFS | 0 | $0 | 2,353 | $72,388 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-25 | BLFS | Sale | 347 | 10.99 | 3,813 |
| 2023-08-14 | BLFS | Sale | 108 | 12.38 | 1,337 |
| 2023-07-24 | BLFS | Sale | 679 | 19.50 | 13,240 |
| 2023-07-11 | BLFS | Sale | 331 | 22.79 | 7,543 |
| 2023-05-31 | BLFS | Sale | 337 | 23.21 | 7,821 |
| 2023-05-15 | BLFS | Sale | 75 | 18.71 | 1,403 |
| 2023-04-19 | BLFS | Sale | 430 | 19.33 | 8,311 |
| 2023-04-14 | BLFS | Sale | 215 | 21.05 | 4,525 |
| 2023-04-06 | BLFS | Sale | 771 | 20.03 | 15,443 |
| 2023-03-01 | BLFS | Sale | 903 | 22.75 | 20,543 |
| 2023-02-09 | BLFS | Sale | 56 | 24.60 | 1,377 |
| 2023-01-23 | BLFS | Sale | 1,000 | 25.02 | 25,020 |
| 2023-01-18 | BLFS | Sale | 3,000 | 25.04 | 75,120 |
| 2023-01-19 | BLFS | Sale | 538 | 22.93 | 12,336 |
| 2023-01-11 | BLFS | Sale | 258 | 21.94 | 5,660 |
| 2022-11-10 | BLFS | Sale | 40 | 23.16 | 926 |
| 2022-10-28 | BLFS | Sale | 400 | 21.76 | 8,704 |
| 2022-10-14 | BLFS | Sale | 236 | 21.80 | 5,144 |
| 2022-08-10 | BLFS | Sale | 42 | 23.17 | 973 |
| 2022-08-03 | BLFS | Sale | 4,600 | 20.03 | 92,138 |
| 2022-07-22 | BLFS | Sale | 367 | 17.94 | 6,583 |
| 2022-07-12 | BLFS | Sale | 254 | 15.79 | 4,010 |
| 2022-05-13 | BLFS | Sale | 41 | 12.32 | 505 |
| 2022-04-21 | BLFS | Sale | 477 | 13.94 | 6,649 |
| 2022-04-18 | BLFS | Sale | 286 | 17.59 | 5,030 |
| 2022-02-10 | BLFS | Sale | 167 | 29.38 | 4,906 |
| 2022-01-20 | BLFS | Sale | 395 | 30.24 | 11,944 |
| 2022-01-12 | BLFS | Sale | 267 | 32.18 | 8,592 |
| 2021-11-09 | BLFS | Sale | 1,750 | 53.00 | 92,750 |
| 2021-10-20 | BLFS | Sale | 399 | 42.34 | 16,893 |
| 2021-10-11 | BLFS | Sale | 245 | 38.22 | 9,363 |
| 2021-07-26 | BLFS | Sale | 4,919 | 46.13 | 226,913 |
| 2021-07-20 | BLFS | Sale | 2,539 | 45.10 | 114,508 |
| 2021-07-08 | BLFS | Sale | 240 | 45.73 | 10,976 |
| 2021-04-20 | BLFS | Sale | 650 | 32.10 | 20,865 |
| 2021-01-12 | BLFS | Sale | 2,000 | 41.01 | 82,020 |
| 2021-01-08 | BLFS | Sale | 293 | 39.01 | 11,429 |
| 2020-11-12 | BLFS | Sale | 1,400 | 32.51 | 45,514 |
| 2020-10-12 | BLFS | Sale | 953 | 28.20 | 26,874 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schulz Marcus (Chief Revenue Officer of Biolife Solutions Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.